Episode 41: Tough Calls & Transformative Science- A Journey Through Strategy and Innovation

episode

ATCC's Podcast: Behind the Biology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded17 Feb 2026

Publisherfast.wistia.com ↗

Handlerec:15956851

Show notes

Listen in to hear Dr. Ruth Cheng dive into the pivotal career moments that shaped her leadership style and strategic mindset. She recounts leading a therapeutic delivery project at Boston Scientific that she ultimately chose to terminate—an experience that taught her the value of recognizing failure early and reallocating resources wisely. At Smith & Nephew, she embraced a high-stakes strategic planning role without prior experience, relying on mentorship and collaboration. Dr. Cheng also discusses ATCC’s evolution from 2D to advanced 3D cultures and the growing need for standards that support complex biological research, especially in the era of personalized medicine and engineered biology.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in